Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Acknowledgement to Contributors56
Acknowledgement to Reviewers52
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy34
ZNF146-Mediated HMGB1-NF-κB Signaling Activation as a Therapeutic Target and Prognostic Biomarker in Osteosarcoma31
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration20
Research Progress on the Anticancer Activity of Plant Polysaccharides18
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway18
Protective Assessment of Novel (BNC Formulation) against Brain Tumor17
Patent Selections17
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer17
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review17
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review15
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents15
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment14
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer14
The Present State and Potential Applications of Artificial Intelligence in Cancer Diagnosis and Treatment14
Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway14
Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma with Radiotherapy Interruptions: A Lesson Learned from the Lockdown Due to COVID-1914
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer14
0.085024833679199